# VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease

> **NCT03257345** · — · UNKNOWN · sponsor: **University Hospital Southampton NHS Foundation Trust** · enrollment: 360 (estimated)

## Conditions studied

- Ulcerative Colitis
- Crohn's Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03257345
- **Lead sponsor:** University Hospital Southampton NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-02-03
- **Primary completion:** 2019-09-30
- **Final completion:** 2019-12-31
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2018-09-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03257345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03257345, "VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03257345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*